DOTA-(Tyr3)-Octreotate,CAS :177943-89-4
DOTA-(Tyr3)-Octreotate
Product description
DOTA-conjugated somatostatin analog for labeling with radiometals such as gallium-67 or gallium-68, indiuM-111, and yttrium-90. Potentially useful for receptor-mediated tumor imaging and peptide receptor-targeted radionuclide therapy.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Cas | 177943-89-4 |
| Sequence | 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH (Disulfide bond) |
| One letter sequence | DOTA-fCYwKTCT (Cys & Cys bridge) |
| Molecular formula | C65H90N14O19S2 |
| Storage | -20℃,protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of DOTA-(Tyr3)-Octreotate
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


